Sponsor Perspective: Alexion Pharmaceuticals | Rare Disease Day: 40 Years of the Orphan Drug Act - YouTube
CMA investigating AstraZeneca's anticipated £27.6bn buyout of Alexion :: C+D
Alexion to expand biologics manufacturing with €65m investment
AstraZeneca's Alexion, Arvinas nab space at future 10-story biotech tower in New Haven | Fierce Biotech
Alexion finally has a buyer – and it's AstraZeneca with $39bn on the table | pharmaphorum
AstraZeneca acquires US drug developer Alexion in massive $39 billion deal | International Business
Alexion
UK regulator reviewing AstraZeneca's $39 bln Alexion buyout | Reuters
AstraZeneca to Acquire Alexion – ISPE Boston
AstraZeneca celebrates copper-bottomed deal after Alexion purchase
Alexion | MMA Global
Alexion moving to Boston but keeping 450 workers in New Haven
Articles about Alexion
File:Alexion Pharmaceuticals logo.svg - Wikipedia
AstraZeneca buys rare disease drugmaker Caelum in potential $500 mln deal | Reuters
Alexion Pharmaceuticals - Crunchbase Company Profile & Funding
Alexion
Sep 21, 2020 South San Francisco / CA / USA - Alexion logo at their headquarters in Silicon Valley; Alexion Pharmaceuticals, Inc. develops treatments Stock Photo - Alamy
UK regulators to review AstraZeneca's €32bn Alexion buyout - Industry Europe
Alexion Pharmaceuticals invests in New Haven - Yale Daily News
Alexion Pharmaceuticals, Logo, White background Stock Photo - Alamy
New warehouse earmarked for Alexion site | Westmeath Independent
Alexion to build €100m facility in Athlone
File:Alexion Logo.svg - Wikimedia Commons
Alexion Pharmaceuticals to Acquire Achillion in $930 Million Deal - TheStreet
Alexion - American Bone Health
